• Home
  • NEW DAY MEDICINE
  • 11 (49) 2022
  • 7 -11 (49) 2022 — Ashurova N.G. Kayumov U.K., — THE EFFICIENCY OF NON-DRUG PREVENTION OF CARBOHYDRATE METABOLISM DISTURBANCES

7 -11 (49) 2022 — Ashurova N.G. Kayumov U.K., — THE EFFICIENCY OF NON-DRUG PREVENTION OF CARBOHYDRATE METABOLISM DISTURBANCES

THE EFFICIENCY OF NON-DRUG PREVENTION OF CARBOHYDRATE METABOLISM DISTURBANCES

Ashurova N.G. Bukhara State Medical Institute

Kayumov U.K. Center for advanced training of medical personnel

Resume

One of the main tasks of the healthcare system in many countries of the world is the development and implementation of measures for primary and secondary prevention of the occurrence and progression of socially significant diseases. In recent decades, the prevalence of carbohydrate metabolism disorders and DM in particular has acquired the character of a pandemic, both in developed and developing countries of the world. According to the forecasts of the International Diabetes Federation, 642 million people will suffer from diabetes in 2040. Such a rapid increase in the incidence of diabetes was the reason for the adoption of UN Resolution 61/225 of December 20, 2006 on diabetes mellitus, and in 2011 – the UN Political Declaration addressed to national health systems, calling for the creation of multidisciplinary strategies in the field of prevention and control of noncommunicable diseases, where special attention is drawn to the problem of diabetes, as one of the leading causes of disability and mortality in the population.

Keywords: carbohydrate metabolism, impaired glucose tolerance, prediabetes, insulin resistance

First page

38

Last page

47

For citation: Ashurova N.G. Kayumov U.K., – THE EFFICIENCY OF NON-DRUG PREVENTION OF CARBOHYDRATE METABOLISM DISTURBANCES //New DAy in Medicine 11(49)2022 38-47 https://clck.ru/32ddT2

LIST OF REFERENCES:

  1. Алимов А.В., Хайдарова Ф.А., Бердыкулова Д.М. и др. Основные показатели эндокринологической службы Республики Узбекистан за 5 лет (2013-2017 гг.) // Информационно-статистический сборник. – Ташкент, 2019. – 32 с.
  2. Акимбаева Ж. Распространенность артериальной гипертензии и современные проблемы ее контроля // Медицина и экология. – 2014. – №4 –С. 73.
  3. Ашурова Н.Г. (2016). О натуре лекарственных средств в древневосточной медицине. // Биология и интегративная медицина, (2), 189-199.
  4. Ашурова Нодира Гафуровна (2020). Прополис и современные медикаменты. // Биология и интегративная медицина, (2 (42)), 140-156.
  5. Ашурова, Н.Г. (2022). Гипергликемия: Стратегия Профилактики Различных Категорий Гипергликемий (Обзорная Статья). // Central Asian journal of medical and natural sciences, 3(4), 158-165. Retrieved from https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/991
  6. Ashurova N.G. Principles of treatment of anemia with chronic heart Failure International Journal for Innovative Engineering and Management Research (A Peer Revieved Open Access International Journal) Vol 11 Issue 06, 1419-1423.
  7. ВОЗ. Информационный бюллетень. – Июнь, 2016.
  8. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION) // Сахарный диабет. – 2016. – Т. 19, №2. – C. 104-112.
  9. Дедов И.И., Шестакова М.В., Андреева Е.Н., и др. Сахарный диабет: диагностика, лечение, профилактика; Под ред. И.И. Дедова, М.В. Шестаковой. – М., 2011.
  10. International Diabetes Federation 2011. Global Burden: Prevalence and Projections, 2011 and 2030. Available from http://www.diabetesatlas.org/content/diabetes­and­impairedglucose­tolerane
  11. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999. Report no. 99.2. http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2. pdf
  12. World Health Organization (WHO) Consultation. Definition and diagnosis of diabetes and intermediate hyperglycaemia.2006. http://www.who.int/diabetes/publications/Definition20and20 diagnosis20of20diabetes_new.pdf
  13. Резолюция Генеральной Ассамблеи ООН №61
  14. Hansen L.J., Siersma V., Beck-Nielsen H., de Fine Olivarius N. Structured personal care of type 2 diabetes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP) // Diabetologia. – 2013. – Vol. 56, №6. – Р. 1243-1253.
  15. Hansson L., Zanchetti A., Carruthers S.G. et al. НОТ (Hypertension Optimal Treatment) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertsion: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT study group // Lancet. – 1998. – Vol. 351. – P. 1755-1762.
  16. Katakami N. Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus // J. Atheroscleros. Thromb. – 2018. – Vol. 25, №1. – Р. 27-39.
  17. Kelly P.J., Clarke P.M., Hayes A.J. et al. Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data // Diab. Med. – 2014. – Vol. 31, №8. – Р. 954-962.
  18. Курникова И.А., Кочемасова Т.В. Немедикаментозные методы в терапии эндокринных заболеваний: современное состояние проблемы // Фундаментальные исследования. – 2014. – № 10-9. – С. 1858-1865; URL: https://fundamental-research.ru/ru/article/view?id=36528 (дата обращения: 30.08.2022).
  19. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183–1197.
  20. Genuth S., Alberti K.G., Bennett P. et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160–3167.

file

download